Literature DB >> 15923568

2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.

Mariëtte C A van Kouwen1, Fokko M Nagengast, Jan B M J Jansen, Wim J G Oyen, Joost P H Drenth.   

Abstract

PURPOSE: 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) is a noninvasive imaging technique used clinically to detect malignant tumors. FDG-PET has been established as a tool for diagnosis of recurrent or metastatic colorectal carcinoma. Several case series suggest that FDG-PET also detects larger adenomas. The goal of this study was to investigate whether FDG-PET is able to detect colonic adenomas. PATIENTS AND METHODS: FDG-PET was performed in 100 consecutive patients in whom colonic adenomas were suspected on barium enema (n = 47) or sigmoidoscopy (n = 53). A positive scan was defined as focal large bowel FDG accumulation. FDG-PET was followed in all cases by colonoscopy, and removed adenomas were examined histopathologically.
RESULTS: Colonoscopy confirmed the presence of adenomas in 68 of 100 patients. In 35 patients, there was focal FDG accumulation at site of the adenoma. The sensitivity of FDG-PET increased with adenoma size (21%, adenomas 1 to 5 mm; 47%, 6 to 10 mm; and 72%, > 11 mm). The sensitivity of FDG-PET also increased with the grade of dysplasia (33%, low grade; 76%, high grade; and 89%, carcinomas). The overall specificity was 84%.
CONCLUSION: FDG-PET detects colonic adenomas and the diagnostic test characteristics improve with size and grade of dysplasia of the adenoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923568     DOI: 10.1200/JCO.2005.02.401

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  22 in total

1.  Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off.

Authors:  Wolfgang Luboldt; Teresa Volker; Bärbel Wiedemann; Klaus Zöphel; Ursula Wehrmann; Arne Koch; Todd Toussaint; Nasreddin Abolmaali; Markus Middendorp; Daniela Aust; Jörg Kotzerke; Frank Grünwald; Thomas J Vogl; Hans-Joachim Luboldt
Journal:  Eur Radiol       Date:  2010-05-26       Impact factor: 5.315

2.  Application of (18)F-fluorodeoxyglucose positron emission tomography to detection of proximal lesions of obstructive colorectal cancer.

Authors:  Shusuke Mori; Kazuhiro Oguchi
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

3.  Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.

Authors:  Mariëtte C A van Kouwen; Joost P H Drenth; J Han J M van Krieken; Harry van Goor; Pieter Friederich; Wim J G Oyen; Fokko M Nagengast
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-16       Impact factor: 9.236

4.  Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings.

Authors:  Julian Kirchner; Benedikt M Schaarschmidt; Firas Kour; Lino M Sawicki; Ole Martin; Johannes Bode; Stephan Vom Dahl; Verena Keitel; Dieter Häussinger; Christina Antke; Christian Buchbender; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-07       Impact factor: 9.236

5.  Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT).

Authors:  Tomoko Hirakawa; Jun Kato; Yoshihiro Okumura; Keisuke Hori; Sakuma Takahashi; Hideyuki Suzuki; Mitsuhiro Akita; Reiji Higashi; Shunsuke Saito; Eisuke Kaji; Toshio Uraoka; Sakiko Hiraoka; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2011-10-08       Impact factor: 7.527

6.  [Autoregulatory growth control of adenomatous polyps and carcinogenesis in the colorectal region. Basics of tumor surgery Part I].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

7.  Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.

Authors:  Jihye Yun; Carlo Rago; Ian Cheong; Ray Pagliarini; Philipp Angenendt; Harith Rajagopalan; Kerstin Schmidt; James K V Willson; Sandy Markowitz; Shibin Zhou; Luis A Diaz; Victor E Velculescu; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Science       Date:  2009-08-06       Impact factor: 47.728

8.  Advanced adenoma diagnosis with FDG PET in a visibly normal mucosa: a case report.

Authors:  Bhavya Rehani; Richard M Chasen; Yvonne Dowdy; Ankur Bharija; Martin Satter; Pamela Strohmeyer; Joseph Mantil
Journal:  J Med Case Rep       Date:  2007-09-20

9.  Sensitivity of 2-[18F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals.

Authors:  Masau Sekiguchi; Yasuo Kakugawa; Takashi Terauchi; Minori Matsumoto; Hiroshi Saito; Yukio Muramatsu; Yutaka Saito; Takahisa Matsuda
Journal:  J Gastroenterol       Date:  2016-03-28       Impact factor: 7.527

10.  Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake?

Authors:  Cornelia Bettina Brendle; Philip Aschoff; Thomas Kratt; Christina Schraml; Matthias Reimold; Claus Detlef Claussen; Christina Anna Pfannenberg
Journal:  Korean J Radiol       Date:  2013-11-05       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.